Ribupatide for weight loss in adults without diabetes
Part of Hormones & metabolism clinical trials.
This trial tests a new medication, Ribupatide, to see if it helps people with obesity or overweight who also have weight-related health problems. You cannot have diabetes to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a BMI of 30 or higher, or a BMI of 27 or higher with at least one condition like high blood pressure, high cholesterol, sleep apnea, or heart disease.
- You have tried to lose weight with diet or exercise in the last 6 months but it didn't work well enough.
- You do not have diabetes now or in the past.
- You have not taken certain weight-affecting medications (like some antidepressants or antipsychotics) in the last 3 months.
- Your weight has not changed by more than 5% in the last 3 months.
- You do not have a history of certain thyroid cancers, pancreatitis, or serious stomach issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new once-weekly injection called Ribupatide for weight loss in people with obesity who do not have diabetes. It compares the study drug to an existing medication (semaglutide) and a placebo to see how well it works and if it's safe.
This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.
This study tests if tirzepatide helps people with obesity lose weight, whether or not they have type 2 diabetes. It aims to see how safe and effective the drug is.
This trial tests two new medicines, alone or together, to see if they help with weight loss and blood sugar control in adults who have type 2 diabetes and are overweight or have obesity.
This clinical trial tests new treatments for adults who are overweight or have obesity. The goal is to help people lose weight and improve their health.
This study tests a new medicine called berobenatide to help people with overweight or obesity lose weight. The medicine may also help improve related health conditions like high blood pressure, high cholesterol, or type 2 diabetes.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.